To finally assess whether female sex hormones can directly enhance the initiation of KRasG12D-driven lung cancer, we implanted RANK-sufficient female mice with the synthetic progesterone derivative (progestin) medroxyprogesterone acetate (MPA). The gene discussed is TNFRSF11A; the disease is lung carcinoma.